Imagion Biosystems Statistics
Total Valuation
ASX:IBX has a market cap or net worth of AUD 2.62 million. The enterprise value is 2.79 million.
Market Cap | 2.62M |
Enterprise Value | 2.79M |
Important Dates
The next estimated earnings date is Friday, May 30, 2025.
Earnings Date | May 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ASX:IBX has 201.34 million shares outstanding. The number of shares has increased by 47.45% in one year.
Current Share Class | n/a |
Shares Outstanding | 201.34M |
Shares Change (YoY) | +47.45% |
Shares Change (QoQ) | +75.55% |
Owned by Insiders (%) | 13.53% |
Owned by Institutions (%) | 1.02% |
Float | 153.01M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.98 |
PB Ratio | -1.15 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.35 |
EV / Sales | 1.05 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.55
Current Ratio | 0.55 |
Quick Ratio | 0.53 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -0.65 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -12.64% |
Return on Invested Capital (ROIC) | -33.20% |
Return on Capital Employed (ROCE) | 32.75% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.72 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.43% in the last 52 weeks. The beta is 1.59, so ASX:IBX's price volatility has been higher than the market average.
Beta (5Y) | 1.59 |
52-Week Price Change | -82.43% |
50-Day Moving Average | 0.02 |
200-Day Moving Average | 0.03 |
Relative Strength Index (RSI) | 43.75 |
Average Volume (20 Days) | 416,693 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:IBX had revenue of AUD 2.67 million and -2.07 million in losses. Loss per share was -0.05.
Revenue | 2.67M |
Gross Profit | 2.26M |
Operating Income | -747,570 |
Pretax Income | -2.07M |
Net Income | -2.07M |
EBITDA | -700,085 |
EBIT | -747,570 |
Loss Per Share | -0.05 |
Balance Sheet
The company has 2.67 million in cash and 2.85 million in debt, giving a net cash position of -176,784 or -0.00 per share.
Cash & Cash Equivalents | 2.67M |
Total Debt | 2.85M |
Net Cash | -176,784 |
Net Cash Per Share | -0.00 |
Equity (Book Value) | -2.28M |
Book Value Per Share | -0.01 |
Working Capital | -2.30M |
Cash Flow
Operating Cash Flow | -1.27M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 84.95%, with operating and profit margins of -28.05% and -77.56%.
Gross Margin | 84.95% |
Operating Margin | -28.05% |
Pretax Margin | -77.56% |
Profit Margin | -77.56% |
EBITDA Margin | -26.27% |
EBIT Margin | -28.05% |
FCF Margin | n/a |
Dividends & Yields
ASX:IBX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -47.45% |
Shareholder Yield | -47.45% |
Earnings Yield | -78.97% |
FCF Yield | n/a |
Stock Splits
The last stock split was on November 16, 2023. It was a reverse split with a ratio of 0.025.
Last Split Date | Nov 16, 2023 |
Split Type | Reverse |
Split Ratio | 0.025 |
Scores
ASX:IBX has an Altman Z-Score of -34.04. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -34.04 |
Piotroski F-Score | n/a |